| Objectives | |||
| The goal of the fund is to invest into: | |||
| • | Belgian
and European SMEs bringing high technological value. They must exists
for less than 5 years with products at pre commercial stage. By SMEs,
it is understood: |
||
| • | Less than 250 employees | ||
| • | A turnover lower than €40 million or net assets not worth more than €27 million | ||
| • | An independent company, which capital is not owned by a large non SME company for more than 25% | ||
| • | Spin-off from universities and research centres, all over Europe | ||
| • | Spin-off from UCL, which want to move from their proof of product to a proof of market stage | ||
Whenever
possible and in the interest of all stakeholders, a collaboration will
be forged with UCL |
|||
| Fund characteristics | |||
VIVES
is an anonymous company with 15 million capital invested by SOPARTEC
S.A. (13%), the European Investment Fund – EIF (30%), Fortis Private
Equity (17%), KBC Investco (17%), Nivelinvest (13%) and Sofina (10%). |
|||
| VIVES is a closed-end fund limited to 12 years. | |||
| Site Map | |||